※ PTMD 2.0 database Online Browse Options

Browse result for Metastatic melanoma

※ introduction

    Melanoma is the most dangerous type of skin cancer; it develops from the melanin-producing cells known as melanocytes. It typically occurs in the skin, but may rarely occur in the mouth, intestines, or eye (uveal melanoma). In women, melanomas most commonly occur on the legs; while in men, on the back. Melanoma is frequently referred to as malignant melanoma. However, the medical community stresses that there is no such thing as a 'benign melanoma' and recommends that the term 'malignant melanoma' should be avoided as redundant. About 25% of melanomas develop from moles. Changes in a mole that can indicate melanoma include increase¡ªespecially rapid increase¡ªin size, irregular edges, change in color, itchiness, or skin breakdown. The primary cause of melanoma is ultraviolet light (UV) exposure in those with low levels of the skin pigment melanin. The UV light may be from the sun or other sources, such as tanning devices. Those with many moles, a history of affected family members, and poor immune function are at greater risk. A number of rare genetic conditions, such as xeroderma pigmentosum, also increase the risk. Diagnosis is by biopsy and analysis of any skin lesion that has signs of being potentially cancerous. Avoiding UV light and using sunscreen in UV-bright sun conditions may prevent melanoma. Treatment typically is removal by surgery of the melanoma and the potentially affected adjacent tissue bordering the melanoma. In those with slightly larger cancers, nearby lymph nodes may be tested for spread (metastasis). Most people are cured if metastasis has not occurred. For those in whom melanoma has spread, immunotherapy, biologic therapy, radiation therapy, or chemotherapy may improve survival. With treatment, the five-year survival rates in the United States are 99% among those with localized disease, 65% when the disease has spread to lymph nodes, and 25% among those with distant spread. The likelihood that melanoma will reoccur or spread depends on its thickness, how fast the cells are dividing, and whether or not the overlying skin has broken down. Melanoma is the most dangerous type of skin cancer. Globally, in 2012, it newly occurred in 232,000 people. In 2015, 3.1 million people had active disease, which resulted in 59,800 deaths. Australia and New Zealand have the highest rates of melanoma in the world. High rates also occur in Northern Europe and North America, while it is less common in Asia, Africa, and Latin America. In the United States, melanoma occurs about 1.6 times more often in men than women. Melanoma has become more common since the 1960s in areas mostly populated by people of European descent.

Reference
Wiki: Metastatic melanoma



PTMD IDUniProt AccessionEntrez IDGene NameProtein NameOrganism
PTMD00475O751169475
ROCK2
Rho-associated protein kinase 2
Homo sapiens
PTMD01477P062412534
FYN
Tyrosine-protein kinase Fyn
Homo sapiens
PTMD01528P162345156
PDGFRA
Platelet-derived growth factor receptor alpha
Homo sapiens
PTMD01705P785275591
PRKDC
DNA-dependent protein kinase catalytic subunit
Homo sapiens
PTMD01845Q8WZ427273
TTN
Titin
Homo sapiens
PTMD01179Q9H79279834
PEAK1
Inactive tyrosine-protein kinase PEAK1
Homo sapiens
PTMD02267O00238658
BMPR1B
Bone morphogenetic protein receptor type-1B
Homo sapiens
PTMD03246O760396792
CDKL5
Cyclin-dependent kinase-like 5
Homo sapiens
PTMD03502O957479943
OXSR1
Serine/threonine-protein kinase OSR1
Homo sapiens
PTMD05696P5705910272
SIK1
Serine/threonine-protein kinase SIK1
Homo sapiens
PTMD06305Q088813702
ITK
Tyrosine-protein kinase ITK/TSK
Homo sapiens
PTMD06921Q1520811329
STK38
Serine/threonine-protein kinase 38
Homo sapiens
PTMD08520Q6ZN1638984
MAP3K15
Mitogen-activated protein kinase kinase kinase 15
Homo sapiens
PTMD10853Q9291811184
MAP4K1
Mitogen-activated protein kinase kinase kinase kinase 1
Homo sapiens
PTMD12497Q9C0K755437
STRADB
STE20-related kinase adapter protein beta
Homo sapiens
PTMD13906Q9P28657144
PAK5
Serine/threonine-protein kinase PAK 5
Homo sapiens
PTMD14821Q9Y4639149
DYRK1B
Dual specificity tyrosine-phosphorylation-regulated kinase 1B
Homo sapiens